Back to DE D. E. Shaw & Co., Inc.

IBRXIBRX
6 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in IMMUNITYBIO INC

D. E. Shaw & Co., Inc. holds 12.6M shares of IBRX (IMMUNITYBIO INC), worth $96.4M as of 2026-Q1. This is a new position. IBRX represents 0.1% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$96.4M

Current Shares

12.6M

Total Value Change

+$96.4M

Total Shares Change

+12.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
12.6M
-
$96.4M0.1%$10.00
41
2025-Q3
Exited
0
-100.0%
$00.0%$2.57
0
2025-Q2
New
237,147
-
$626,0680.0%$2.70
34
2024-Q4
Exited
0
-100.0%
$00.0%$2.68
0
2024-Q3
New
520,053
-
$1.9M0.0%$3.93
36
2024-Q2
Exited
0
-100.0%
$00.0%$6.32
0

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used